Northern Trust’s Matinas BioPharma MTNB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-8,606
Closed -$68.1K 4436
2024
Q2
$68.1K Sell
8,606
-7
-0.1% -$55 ﹤0.01% 4143
2024
Q1
$117K Buy
8,613
+1,367
+19% +$18.5K ﹤0.01% 4036
2023
Q4
$78.3K Hold
7,246
﹤0.01% 4158
2023
Q3
$47.1K Hold
7,246
﹤0.01% 4182
2023
Q2
$130K Sell
7,246
-23
-0.3% -$414 ﹤0.01% 3965
2023
Q1
$171K Buy
7,269
+337
+5% +$7.92K ﹤0.01% 3913
2022
Q4
$173K Hold
6,932
﹤0.01% 3930
2022
Q3
$220K Buy
6,932
+566
+9% +$18K ﹤0.01% 3835
2022
Q2
$251K Hold
6,366
﹤0.01% 3806
2022
Q1
$256K Sell
6,366
-250
-4% -$10.1K ﹤0.01% 4030
2021
Q4
$334K Hold
6,616
﹤0.01% 3975
2021
Q3
$430K Buy
6,616
+176
+3% +$11.4K ﹤0.01% 3821
2021
Q2
$250K Hold
6,440
﹤0.01% 4059
2021
Q1
$338K Buy
6,440
+933
+17% +$49K ﹤0.01% 3940
2020
Q4
$374K Sell
5,507
-103
-2% -$7K ﹤0.01% 3796
2020
Q3
$215K Sell
5,610
-25
-0.4% -$958 ﹤0.01% 3804
2020
Q2
$218K Sell
5,635
-366
-6% -$14.2K ﹤0.01% 3738
2020
Q1
$180K Buy
6,001
+1,233
+26% +$37K ﹤0.01% 3704
2019
Q4
$542K Buy
4,768
+32
+0.7% +$3.64K ﹤0.01% 3538
2019
Q3
$149K Hold
4,736
﹤0.01% 3835
2019
Q2
$203K Buy
4,736
+1,097
+30% +$47K ﹤0.01% 3821
2019
Q1
$198K Sell
3,639
-14
-0.4% -$762 ﹤0.01% 3784
2018
Q4
$109K Buy
3,653
+582
+19% +$17.4K ﹤0.01% 3901
2018
Q3
$141K Hold
3,071
﹤0.01% 3953
2018
Q2
$67K Sell
3,071
-10,055
-77% -$219K ﹤0.01% 4078
2018
Q1
$502K Buy
13,126
+355
+3% +$13.6K ﹤0.01% 3566
2017
Q4
$741K Sell
12,771
-158
-1% -$9.17K ﹤0.01% 3479
2017
Q3
$854K Buy
12,929
+1,343
+12% +$88.7K ﹤0.01% 3470
2017
Q2
$980K Buy
+11,586
New +$980K ﹤0.01% 3448